Posted in | News | Mining Business

Caribou Updates Progress at Mulloy Graphite Project

CARIBOU KING RESOURCES LTD. has posted the 1.6 kilometer-long geophysical cross-section for its Mulloy graphite project, located ten kilometers west of the Zenyatta Ventures Ltd. Albany graphite project in Ontario.

The cross-section identifies four electromagnetic (EM) conductors along a north-south line that crosses the approximate position of a historical drill hole that encountered high visual graphite over 38.46 meters (see news release, August 15, 2013).

Re-examination of the data indicates that the geophysical cross-section, initially reported to be 325 meters in length (see news release, September 10, 2013), is actually 1,600 meters in length, with the four individual EM lows (conductors) each separated by roughly 300 meters over 900 meters of the survey length.

Michael England, CEO & Director states, “The Mulloy graphite property continues to provide positive indicators as we evaluate our data. The multiple conductors are of significantly greater magnitude than initially realized, and we look forward to completing the entire survey in order to identify targets for drilling later this season.”

The Company has also implemented a Phase 2 program of mapping and sampling at its 100%-owned Calumet property, where lithologies that include graphitic marble were recently identified (see news release, September 18, 2013). The Calumet Graphite prospect is contiguous to Canada Carbon’s (TSX-V: CCB) Miller hydrothermal lump-vein graphite mine, located approximately 96 kilometers west of Montreal.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.